Logo image of YAR.OL

YARA INTERNATIONAL ASA (YAR.OL) Stock Fundamental Analysis

OSL:YAR - Euronext Oslo - NO0010208051 - Common Stock - Currency: NOK

377.2  -2.1 (-0.55%)

Fundamental Rating

4

Taking everything into account, YAR scores 4 out of 10 in our fundamental rating. YAR was compared to 66 industry peers in the Chemicals industry. YAR has an average financial health and profitability rating. YAR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year YAR was profitable.
YAR had a positive operating cash flow in the past year.
YAR had positive earnings in each of the past 5 years.
YAR had a positive operating cash flow in each of the past 5 years.
YAR.OL Yearly Net Income VS EBIT VS OCF VS FCFYAR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

YAR has a Return On Assets of 1.85%. This is comparable to the rest of the industry: YAR outperforms 59.09% of its industry peers.
The Return On Equity of YAR (3.86%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 6.87%, YAR is in the better half of the industry, outperforming 71.21% of the companies in the same industry.
YAR had an Average Return On Invested Capital over the past 3 years of 10.26%. This is above the industry average of 6.51%.
Industry RankSector Rank
ROA 1.85%
ROE 3.86%
ROIC 6.87%
ROA(3y)5.28%
ROA(5y)4.52%
ROE(3y)11.06%
ROE(5y)9.6%
ROIC(3y)10.26%
ROIC(5y)9.83%
YAR.OL Yearly ROA, ROE, ROICYAR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 2.05%, YAR is in line with its industry, outperforming 54.55% of the companies in the same industry.
YAR's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 7.91%, YAR is in the better half of the industry, outperforming 65.15% of the companies in the same industry.
YAR's Operating Margin has declined in the last couple of years.
YAR's Gross Margin of 27.32% is in line compared to the rest of the industry. YAR outperforms 42.42% of its industry peers.
In the last couple of years the Gross Margin of YAR has remained more or less at the same level.
Industry RankSector Rank
OM 7.91%
PM (TTM) 2.05%
GM 27.32%
OM growth 3Y-15.9%
OM growth 5Y-3.81%
PM growth 3Y-66.57%
PM growth 5Y-53.53%
GM growth 3Y-0.02%
GM growth 5Y-0.33%
YAR.OL Yearly Profit, Operating, Gross MarginsYAR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

YAR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for YAR remains at a similar level compared to 1 year ago.
YAR has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, YAR has a worse debt to assets ratio.
YAR.OL Yearly Shares OutstandingYAR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
YAR.OL Yearly Total Debt VS Total AssetsYAR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.73 indicates that YAR is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.73, YAR is doing good in the industry, outperforming 69.70% of the companies in the same industry.
YAR has a debt to FCF ratio of 8.76. This is a slightly negative value and a sign of low solvency as YAR would need 8.76 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.76, YAR is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
A Debt/Equity ratio of 0.52 indicates that YAR is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.52, YAR perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 8.76
Altman-Z 2.73
ROIC/WACC0.9
WACC7.62%
YAR.OL Yearly LT Debt VS Equity VS FCFYAR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

YAR has a Current Ratio of 1.90. This is a normal value and indicates that YAR is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of YAR (1.90) is comparable to the rest of the industry.
A Quick Ratio of 0.96 indicates that YAR may have some problems paying its short term obligations.
The Quick ratio of YAR (0.96) is worse than 60.61% of its industry peers.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 0.96
YAR.OL Yearly Current Assets VS Current LiabilitesYAR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 175.00% over the past year.
YAR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.01% yearly.
Looking at the last year, YAR shows a decrease in Revenue. The Revenue has decreased by -2.88% in the last year.
YAR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.52% yearly.
EPS 1Y (TTM)175%
EPS 3Y-22.66%
EPS 5Y-11.01%
EPS Q2Q%380.95%
Revenue 1Y (TTM)-2.88%
Revenue growth 3Y-5.85%
Revenue growth 5Y1.52%
Sales Q2Q%10.55%

3.2 Future

Based on estimates for the next years, YAR will show a decrease in Earnings Per Share. The EPS will decrease by -3.29% on average per year.
The Revenue is expected to grow by 2.13% on average over the next years.
EPS Next Y76.67%
EPS Next 2Y35.44%
EPS Next 3Y17.28%
EPS Next 5Y-3.29%
Revenue Next Year6.33%
Revenue Next 2Y2.5%
Revenue Next 3Y2.43%
Revenue Next 5Y2.13%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
YAR.OL Yearly Revenue VS EstimatesYAR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
YAR.OL Yearly EPS VS EstimatesYAR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.68, YAR is valued correctly.
YAR's Price/Earnings ratio is a bit cheaper when compared to the industry. YAR is cheaper than 77.27% of the companies in the same industry.
YAR is valuated rather cheaply when we compare the Price/Earnings ratio to 26.20, which is the current average of the S&P500 Index.
YAR is valuated reasonably with a Price/Forward Earnings ratio of 11.70.
Based on the Price/Forward Earnings ratio, YAR is valued a bit cheaper than the industry average as 75.76% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of YAR to the average of the S&P500 Index (22.13), we can say YAR is valued slightly cheaper.
Industry RankSector Rank
PE 14.68
Fwd PE 11.7
YAR.OL Price Earnings VS Forward Price EarningsYAR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, YAR is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of YAR indicates a somewhat cheap valuation: YAR is cheaper than 71.21% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.26
EV/EBITDA 6.07
YAR.OL Per share dataYAR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400 500

4.3 Compensation for Growth

YAR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as YAR's earnings are expected to grow with 17.28% in the coming years.
PEG (NY)0.19
PEG (5Y)N/A
EPS Next 2Y35.44%
EPS Next 3Y17.28%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.35%, YAR has a reasonable but not impressive dividend return.
YAR's Dividend Yield is comparable with the industry average which is at 3.12.
Compared to an average S&P500 Dividend Yield of 2.40, YAR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.35%

5.2 History

The dividend of YAR decreases each year by -8.80%.
Dividend Growth(5Y)-8.8%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

41.38% of the earnings are spent on dividend by YAR. This is a bit on the high side, but may be sustainable.
YAR's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP41.38%
EPS Next 2Y35.44%
EPS Next 3Y17.28%
YAR.OL Yearly Income VS Free CF VS DividendYAR.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B
YAR.OL Dividend Payout.YAR.OL Dividend Payout, showing the Payout Ratio.YAR.OL Dividend Payout.PayoutRetained Earnings

YARA INTERNATIONAL ASA

OSL:YAR (5/28/2025, 7:00:00 PM)

377.2

-2.1 (-0.55%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-25 2025-04-25/bmo
Earnings (Next)07-18 2025-07-18/bmo
Inst Owners42.95%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap96.08B
Analysts65.38
Price Target361.78 (-4.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.35%
Yearly Dividend4.8
Dividend Growth(5Y)-8.8%
DP41.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.75%
Min EPS beat(2)-47.21%
Max EPS beat(2)37.7%
EPS beat(4)3
Avg EPS beat(4)19.35%
Min EPS beat(4)-47.21%
Max EPS beat(4)50.14%
EPS beat(8)4
Avg EPS beat(8)40.78%
EPS beat(12)6
Avg EPS beat(12)23.78%
EPS beat(16)7
Avg EPS beat(16)11.92%
Revenue beat(2)1
Avg Revenue beat(2)-1.57%
Min Revenue beat(2)-3.34%
Max Revenue beat(2)0.19%
Revenue beat(4)1
Avg Revenue beat(4)-2.83%
Min Revenue beat(4)-4.86%
Max Revenue beat(4)0.19%
Revenue beat(8)1
Avg Revenue beat(8)-8.1%
Revenue beat(12)2
Avg Revenue beat(12)-4.97%
Revenue beat(16)4
Avg Revenue beat(16)-3.46%
PT rev (1m)1.32%
PT rev (3m)2.14%
EPS NQ rev (1m)18.77%
EPS NQ rev (3m)-8.44%
EPS NY rev (1m)0%
EPS NY rev (3m)4.92%
Revenue NQ rev (1m)-2.33%
Revenue NQ rev (3m)2.75%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)-2.48%
Valuation
Industry RankSector Rank
PE 14.68
Fwd PE 11.7
P/S 0.67
P/FCF 20.26
P/OCF 6.07
P/B 1.26
P/tB 1.42
EV/EBITDA 6.07
EPS(TTM)25.7
EY6.81%
EPS(NY)32.23
Fwd EY8.55%
FCF(TTM)18.62
FCFY4.94%
OCF(TTM)62.12
OCFY16.47%
SpS565.2
BVpS299.33
TBVpS265.63
PEG (NY)0.19
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.85%
ROE 3.86%
ROCE 8.99%
ROIC 6.87%
ROICexc 7.05%
ROICexgc 7.58%
OM 7.91%
PM (TTM) 2.05%
GM 27.32%
FCFM 3.29%
ROA(3y)5.28%
ROA(5y)4.52%
ROE(3y)11.06%
ROE(5y)9.6%
ROIC(3y)10.26%
ROIC(5y)9.83%
ROICexc(3y)11.17%
ROICexc(5y)10.65%
ROICexgc(3y)12.02%
ROICexgc(5y)11.5%
ROCE(3y)13.48%
ROCE(5y)12.99%
ROICexcg growth 3Y-20.87%
ROICexcg growth 5Y0.34%
ROICexc growth 3Y-20.66%
ROICexc growth 5Y0.45%
OM growth 3Y-15.9%
OM growth 5Y-3.81%
PM growth 3Y-66.57%
PM growth 5Y-53.53%
GM growth 3Y-0.02%
GM growth 5Y-0.33%
F-Score6
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 8.76
Debt/EBITDA 1.8
Cap/Depr 104.6%
Cap/Sales 7.7%
Interest Coverage 4.23
Cash Conversion 72%
Profit Quality 161.03%
Current Ratio 1.9
Quick Ratio 0.96
Altman-Z 2.73
F-Score6
WACC7.62%
ROIC/WACC0.9
Cap/Depr(3y)107.36%
Cap/Depr(5y)98.34%
Cap/Sales(3y)6.55%
Cap/Sales(5y)6.27%
Profit Quality(3y)1242.99%
Profit Quality(5y)807.54%
High Growth Momentum
Growth
EPS 1Y (TTM)175%
EPS 3Y-22.66%
EPS 5Y-11.01%
EPS Q2Q%380.95%
EPS Next Y76.67%
EPS Next 2Y35.44%
EPS Next 3Y17.28%
EPS Next 5Y-3.29%
Revenue 1Y (TTM)-2.88%
Revenue growth 3Y-5.85%
Revenue growth 5Y1.52%
Sales Q2Q%10.55%
Revenue Next Year6.33%
Revenue Next 2Y2.5%
Revenue Next 3Y2.43%
Revenue Next 5Y2.13%
EBIT growth 1Y140.56%
EBIT growth 3Y-20.82%
EBIT growth 5Y-2.34%
EBIT Next Year149.37%
EBIT Next 3Y35.87%
EBIT Next 5Y15.04%
FCF growth 1Y-69.97%
FCF growth 3Y-28.42%
FCF growth 5Y-24.89%
OCF growth 1Y-39.59%
OCF growth 3Y-2.93%
OCF growth 5Y-7.58%